-

VisionQuest Biomedical LLC, Product Pipeline Analysis - 2019 Update - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "VisionQuest Biomedical LLC - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Summary

VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company's products include EYESTAR, retinal image quality analyzer, ASPIRE, and diabetic neuropathy detection imaging systems. Its EYESTAR product is a total eye disease screening program package, and ASPIRE is a retinal camera device that detects cerebral malarial retinopathy. VisionQuest's imaging analysis and technology is used in ultrasound, ophthalmology, and infrared imaging. The company provides its products for early detection and diagnosis of chronic diseases such as diabetic retinopathy, age-related macular degeneration, glaucoma and cardiovascular disease. It also offers research and development services. VisionQuest is headquartered in Albuquerque, New Mexico, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company VisionQuest Biomedical LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

  • VisionQuest Biomedical LLC Company Overview
  • VisionQuest Biomedical LLC Company Snapshot
  • VisionQuest Biomedical LLC Pipeline Products and Ongoing Clinical Trials Overview
  • VisionQuest Biomedical LLC - Pipeline Analysis Overview
  • VisionQuest Biomedical LLC - Key Facts
  • VisionQuest Biomedical LLC - Major Products and Services
  • VisionQuest Biomedical LLC Pipeline Products by Development Stage
  • VisionQuest Biomedical LLC Pipeline Products Overview
  • Aspire
  • Aspire Product Overview
  • CARV First Reader System
  • CARV First Reader System Product Overview
  • CARV Second Reader System
  • CARV Second Reader System Product Overview
  • ConQuest
  • ConQuest Product Overview
  • DR-RACS
  • DR-RACS Product Overview
  • Functional Scanning Laser Ophthalmoscope
  • Functional Scanning Laser Ophthalmoscope Product Overview
  • i-RxCam
  • i-RxCam Product Overview
  • i-RxTherm
  • i-RxTherm Product Overview
  • Neoscan-Assist
  • Neoscan-Assist Product Overview
  • Real-Time fMRI
  • Real-Time fMRI Product Overview
  • VisionQuest Biomedical LLC - Key Competitors
  • VisionQuest Biomedical LLC - Key Employees
  • VisionQuest Biomedical LLC - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • VisionQuest Biomedical LLC, Recent Developments
  • Sep 10, 2018: VisionQuest Announces Leadership Promotions and Formation of Advisory Board
  • Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer

Companies Mentioned

  • BRIT Systems Inc
  • Coeur Inc
  • Biodex Medical Systems Inc
  • 7 Medical Systems LLC
  • Altrum Technologies, Inc.

For more information about this company profile visit https://www.researchandmarkets.com/r/1wu290

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Future of AI and Private AI Imperative Research Report: Shifting from Proprietary LLMs to Secure, Cost-Effective Enterprise Infrastructure - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Private AI Imperative: Shifting from Proprietary LLMs to Secure, Cost-Effective Enterprise Infrastructure" report has been added to ResearchAndMarkets.com's offering. The current enterprise landscape is at a critical juncture, defined by the pervasive yet challenging adoption of Large Language Models (LLMs). The imperative is clear: organizations must pivot away from reliance on expensive, proprietary LLMs and third-party cloud services to establish a secure, c...

China Alternative Lending Market Report 2025: Size & Forecast by Value and Volume Across 100+ KPIs 2020-2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose, Finance Models, Distribution Channels, and Payment Instruments - Databook Q4 2025 Update" has been added to ResearchAndMarkets.com's offering. China's alternative lending market is set to grow by 15.4% annually, reaching US$153,818.5 million by 2025. The market has shown strong growth from 2020-2024 with a CAGR of 13.7%, and...

Electronic Warfare (EW) Market Research and Technology Forecast Report 2033: Modular Architectures and AI Driving EW Transformation - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Electronic Warfare (EW) - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The global Electronic Warfare (EW) market is entering a transformational phase as defence forces simultaneously modernise 4.5- and 5th-generation platforms and prepare for the arrival of 6th-generation systems. This evolution is driving strong demand for AI-enabled, cognitive EW capabilities and modular, plug-and-play architectures that supp...
Back to Newsroom